Evidence map›Paper›PMID 26512232›Full record

Trial reportGerman medical science : GMS e-journal2015

Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.

Jutta Bleidorn, Sermin Bucak, Ildikó Gágyor, Eva Hummers-Pradier, Marie-Luise Dierks

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in German medical science : GMS e-journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Non-antibiotic treatment of acute urinary tract infection in primary care: a qualitative study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jutta BleidornInstitute for General Practice, Hannover Medical School, Hannover, Germany.
Sermin BucakInstitute for General Practice, Hannover Medical School, Hannover, Germany.
Ildikó GágyorInstitute of General Practice and Family Medicine, University Medical Center, Goettingen, Germany.
Eva Hummers-PradierInstitute of General Practice and Family Medicine, University Medical Center, Goettingen, Germany.
Marie-Luise DierksInstitute for Epidemiology, Social Medicine and Health Systems Research, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsufficient patient recruitment can impair the conduct of clinical trials substantially, not least because a significant number of eligible patients decline trial participation. Though barriers and motivational factors have been worked out for patients with cancer or chronic diseases, little is known about primary care patients' perceptions towards trial participation when visiting their family practitioner (FP) with acute uncomplicated conditions. This study aims to assess primary care patients' motivation and barriers to participate in trials, and to identify factors that optimize patient recruitment in future trials.

methodsThis study was embedded in a drug trial comparing two treatment strategies for women with uncomplicated urinary tract infection in primary care. Semi-structured telephone interviews both with trial participants and decliners were conducted. The interview guideline focused on patients' personal motivational or hampering factors. Further topics were study theme, FPs' role, randomization, trial procedures, and potential motivational factors or barriers presumed to be relevant for other patients. Transcripts were analyzed by summarizing content analysis.

results20 interviews with trial participants and 5 interviews with trial decliners were conducted. RESULTS show various reasons for trial participation from three categories: personal aspects, trial related aspects and patient-physician-relationship. A relevant trial topic and perceived personal benefit promotes participation as well as the wish to support research in general. Additionally, a maximum of safety concerning symptom relief reassures patients significantly. Trust in the FP plays also an important role in the decision process. Trial decliners show strong individual treatment preferences, which, together with individual reasons, lead to trial refusals.

conclusionsTo optimize recruitment conditions for further clinical trials on acute and common conditions in family medicine, the following key issues should be considered: emphasizing patients' personal benefit, featuring patient relevant trial topics, providing a maximum of safety, keeping effort by trial procedures comfortable.

Indexed as

Patient SelectionPhysician's RoleAdultAgedAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalFamily PracticeFemaleFosfomycinGermanyHumansIbuprofenMiddle AgedMotivationPatient ParticipationPatient SafetyAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalFosfomycinIbuprofenclinical trialfamily medicinemotivational factorsnon participationpatients attitudesqualitative researchtrial participationurinary tract infection

Identifiers

PMID26512232
PMCPMC4606084
OpenAlexW2429010674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.